FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
FALSE000181176400018117642023-06-012023-06-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K...
2022 Annual Report POINT BIOPHARMA GLOBAL INC Dr. Joe McCann MESSAGE FROM THE CEO Dr. Joe McCann Chief Executive...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549SCHEDULE 14A(Rule 14a-101)SCHEDULE 14A INFORMATIONProxy Statement Pursuant...
00018117642022FYFALSEP3YP1Y00018117642022-01-012022-12-3100018117642022-06-30iso4217:USD00018117642023-03-22xbrl...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO...
FALSE000181176400018117642023-02-022023-02-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.